Showing results (21-30 of 59) with videos related to

Sort By:
Pageof 6
The Journal of Biological Chemistry|November 5, 1993
Deconjugation of bilirubin-IX alpha glucuronides: a physiologic role of hepatic microsomal beta-glucuronidaseJ F Whiting, J P Narciso, V Chapman, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 2, 2001
Changes in neurocognitive performance in a cohort of patients treated with HAART for 3 yearsV Tozzi, P Balestra, S Galgani, et al.
Gut|January 1, 1993
Zidovudine plus interferon alfa-2b treatment in patients with HIV and chronic active viral hepatitisG Visco, L Alba, S Grisetti, et al.
Nuklearmedizin. Nuclear Medicine|February 1, 1991
Cerebral blood flow in AIDS-related neurotoxoplasmosis: a preliminary 99mTc-HMPAO SPECT studyF Pigorini, C L Maini, F M Pau, et al.
Journal of Medical Virology|June 29, 2007
Virological characterization of patients treated early is able to control HIV-1 replication after multiple cycles of structured therapy interruptionG Rozera, I Abbate, G D'Offizi, et al.
Patient Preference and Adherence|June 11, 2011
Cost of surgical intervention for reconstructive therapy of HIV-associated facial lipoatrophyM Massella, J Ivanovic, R Bellagamba, et al.
Neurology|October 24, 2001
Acute disseminated encephalomyelitis as manifestation of primary HIV infectionP Narciso, S Galgani, B Del Grosso, et al.
International Journal of Immunopathology and Pharmacology|September 21, 2007
An IL-15 dependent CD8 T cell response to selected HIV epitopes is related to viral control in early-treated HIV-infected subjectsG D'Offizi, C Gioia, A Corpolongo, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 24, 2007
Imported malaria at Italy's National Institute for Infectious Diseases Lazzaro Spallanzani, 1984-2003F Spinazzola, E Nicastri, C Vlassi, et al.
Biologics : Targets & Therapy|August 27, 2009
T20QoL: an observational multicenter cohort study to evaluate the quality of life in HIV-patients treated with enfuvirtide (ENF, T-20) in combination with an optimized background therapyR Bucciardini, M Massella, A Corpolongo, et al.
Pageof 6